Design, Synthesis, And Evaluation Of Aryl Hydantoins And Ureas As Antischistosomal Agents
January 2016
in “
Graduate Medical Education Research Journal
”
Studysummary This study identified AH01 derivatives and related compounds with high antischistosomal efficacy and reduced antiandrogenic effects, suggesting potential new directions for schistosomiasis drug development.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study addressed the urgent need for new antischistosomal drugs due to limitations and potential resistance to praziquantel (PZQ). Researchers revisited AH01, an aryl hydantoin compound, confirming its high efficacy against both adult and juvenile schistosomes and its minimal interaction with androgen receptors. They synthesized AH01 analogs to enhance efficacy and reduce antiandrogenic effects, identifying several promising derivatives. Additionally, they discovered that urea carboxylic acid UC00 and AR33, related compounds, also showed significant antischistosomal activity. The most promising new compound was N,N’-di(quinoxalin-2-yl)urea, suggesting a new direction for drug development.
